2021 Q2 Form 10-Q Financial Statement

#000110465921105212 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $27.60M
YoY Change
Gross Profit $35.10M
YoY Change
Gross Profit Margin
Selling, General & Admin $10.70M
YoY Change
% of Gross Profit 30.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.580M
YoY Change
% of Gross Profit 7.35%
Operating Expenses $1.394M
YoY Change
Operating Profit -$1.394M
YoY Change
Interest Expense -$20.26M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$20.26M
YoY Change
Pretax Income -$21.66M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$21.66M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$748.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.05K
YoY Change
Cash & Equivalents $18.05K
Short-Term Investments
Other Short-Term Assets $334.1K
YoY Change
Inventory
Prepaid Expenses $334.1K
Receivables
Other Receivables
Total Short-Term Assets $352.1K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $236.3M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $236.3M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $352.1K
Total Long-Term Assets $236.3M
Total Assets $236.6M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.211M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.251M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $45.52M
YoY Change
Total Long-Term Liabilities $45.52M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.251M
Total Long-Term Liabilities $45.52M
Total Liabilities $47.77M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$47.32M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$47.32M
YoY Change
Total Liabilities & Shareholders Equity $236.6M
YoY Change

Cashflow Statement

Concept 2021 Q2
OPERATING ACTIVITIES
Net Income -$21.66M
YoY Change
Depreciation, Depletion And Amortization $2.580M
YoY Change
Cash From Operating Activities -$436.3K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $970.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$970.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K
YoY Change
NET CHANGE
Cash From Operating Activities -436.3K
Cash From Investing Activities -970.0K
Cash From Financing Activities 40.00K
Net Change In Cash -396.3K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$436.3K
Capital Expenditures $970.0K
Free Cash Flow -$1.406M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21655640
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12724440
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89109
CY2021Q2 us-gaap Assets Current
AssetsCurrent
352100
dei City Area Code
CityAreaCode
650
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1038304
dei Local Phone Number
LocalPhoneNumber
618-2524
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001823144
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236286534
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236215089
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Type
DocumentType
10-Q
dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18045
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
603615
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39687
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
334055
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
434689
dei Entity Registrant Name
EntityRegistrantName
Roman DBDR Tech Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2749902
dei Entity Address Address Line1
EntityAddressAddressLine1
2877 Paradise Rd. #702
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-9956338
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21655640
us-gaap Net Income Loss
NetIncomeLoss
-12724440
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q2 us-gaap Assets
Assets
236638634
CY2020Q4 us-gaap Assets
Assets
237253393
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2211455
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
98112
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
40000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2251455
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98112
CY2021Q2 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
CY2020Q4 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
CY2021Q2 us-gaap Liabilities
Liabilities
47767555
CY2020Q4 us-gaap Liabilities
Liabilities
35657874
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23064036
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10339715
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18065118
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5340678
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236638634
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
237253393
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1393952
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2839547
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1393952
us-gaap Operating Income Loss
OperatingIncomeLoss
-2839547
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
30188
us-gaap Investment Income Interest
InvestmentIncomeInterest
71445
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-24454
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-20267422
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-625570
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9884893
dbdr Proceeds From Other Related Party Debt
ProceedsFromOtherRelatedPartyDebt
40000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20261688
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2113343
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2021Q1 dbdr Change In Value Common Shares Amount
ChangeInValueCommonSharesAmount
8931202
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8931200
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2021Q2 dbdr Change In Value Common Shares Amount
ChangeInValueCommonSharesAmount
-21655647
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21655640
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
us-gaap Profit Loss
ProfitLoss
-12724440
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9956338
us-gaap Investment Income Interest
InvestmentIncomeInterest
71445
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-100634
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-585570
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
603615
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18045
dbdr Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-12724445
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18045
CY2021Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236286534
dbdr Working Capital Deficit
WorkingCapitalDeficit
1799355
CY2021Q2 dbdr Franchise And Income Taxes Payable
FranchiseAndIncomeTaxesPayable
100000
dbdr Interest Income Earned From Trust Account Available To Pay Tax Obligations
InterestIncomeEarnedFromTrustAccountAvailableToPayTaxObligations
95334
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
40000
CY2021Q2 dbdr Total Offering Costs
TotalOfferingCosts
13206613
dbdr Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
4631200
CY2021Q2 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
dbdr Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
470813
CY2021Q2 dbdr Offering Cost Charged To Expense
OfferingCostChargedToExpense
714710
CY2021Q2 dbdr Offering Cost Charged To Stock Holders Equity
OfferingCostChargedToStockHoldersEquity
12491903
CY2021Q2 dbdr Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2021Q2 dbdr Deferred Fee Per Unit
DeferredFeePerUnit
0.35
dbdr Net Tangible Asset
NetTangibleAsset
5000001
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
22415400
CY2021Q2 dbdr Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
5734
dbdr Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
71445
CY2021Q2 dbdr Interest Available To Be Withdrawn For Payment Of Taxes
InterestAvailableToBeWithdrawnForPaymentOfTaxes
5734
dbdr Interest Available To Be Withdrawn For Payment Of Taxes
InterestAvailableToBeWithdrawnForPaymentOfTaxes
71445
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation maximum of $250,000. The Company has not experienced losses on this account.</p>
CY2021Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
30000
dbdr Transaction Costs
TransactionCosts
50000000
dbdr Remaining Trust Cash
RemainingTrustCash
210000000
dbdr Net Indebtedness Of Composecure
NetIndebtednessOfComposecure
250000000
dbdr Amount Of Cash On Hand At Composecure
AmountOfCashOnHandAtComposecure
5000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
23644544
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3810618
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27455162
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
9956338
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
37411500

Files In Submission

Name View Source Status
0001104659-21-105212-index-headers.html Edgar Link pending
0001104659-21-105212-index.html Edgar Link pending
0001104659-21-105212.txt Edgar Link pending
0001104659-21-105212-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210630.xsd Edgar Link pending
tmb-20210630x10q.htm Edgar Link pending
tmb-20210630x10q_htm.xml Edgar Link completed
tmb-20210630xex31d1.htm Edgar Link pending
tmb-20210630xex31d2.htm Edgar Link pending
tmb-20210630xex31d3.htm Edgar Link pending
tmb-20210630xex32d1.htm Edgar Link pending
tmb-20210630xex32d2.htm Edgar Link pending
tmb-20210630xex32d3.htm Edgar Link pending
tmb-20210630_cal.xml Edgar Link unprocessable
tmb-20210630_def.xml Edgar Link unprocessable
tmb-20210630_lab.xml Edgar Link unprocessable
tmb-20210630_pre.xml Edgar Link unprocessable